720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Get to know Mark Abzug, MD
I am interested in Perinatal Infection, Enterovirus Infections and Infections in Immunocompromised Patients.
Medical Education 1982
Boston University School of Medicine
Internship 1983
Strong Memorial Hospital of the University of Rochester Program
Residency 1985
Strong Memorial Hospital of the University of Rochester Program
Fellowship 1988
University of Colorado (University Hospital) Program
For Patients:
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
For Referring Providers:
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
